Aurobindo plans to launch 19 drugs in US in next 3 quarters Industry-The Economic Times — September 4, 2016 comments off Commenting on the OTC segment in the US, Aurobindo Pharma MD N Govindarajan said the company expects a spurt in growth in the second half of 2017-18.
Commenting on the OTC segment in the US, Aurobindo Pharma MD N Govindarajan said the company expects a spurt in growth in the second half of 2017-18.